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Abstract
Background: In autoimmune haemolytic anaemia (AIHA), autoreactive antibodies directed against red blood cells
are up-regulated, leading to erythrocyte death. Mycoplasma suis infections in pigs induce AIHA of both the warm
and cold types. The aim of this study was to identify the target autoantigens of warm autoreactive IgG antibodies.
Sera from experimentally M. suis-infected pigs were screened for autoreactivity.
Results: Actin-reactive antibodies were found in the sera of 95% of all animals tested. The reactivity was species-
specific, i.e. reactivity with porcine actin was significantly higher than with rabbit actin. Sera of animals previously
immunised with the M. suis adhesion protein MSG1 showed reactivity with actin prior to infection with M. suis
indicating that molecular mimicry is involved in the specific autoreactive mechanism. A potentially cross-reactive
epitope was detected.
Conclusions: This is the first report of autoreactive anti-actin antibodies involved in the pathogenesis of
autoimmune haemolytic anaemia.
Background
Haemotrophic mycoplasma infections are found in a
wide range of domestic and wild animals causing acute
haemolytic anaemia or chronic anaemia with immune
suppression [1,2]. Generally, they show distinct host spe-
cificity. However, there are reports of humans infected
with haemotrophic mycoplasmas, i.e. Mycoplasma hae-
mofelis and Mycoplasma suis [3,4]. M. suis causes infec-
tious anaemia in pigs (IAP) [1].
Two forms of autoimmune haemolytic anaemia
(AIHA) have been described: warm AIHA, which is
characterised by autoreactive IgG antibodies binding
their target epitope at body temperature [5], and cold
AIHA. In cold AIHA, complement-activating autoreac-
tive IgM antibodies bind their antigen, usually the l/i
epitope on red blood cells, below body temperature and
are strongly agglutinating at 4°C [6,7]. Both types of
antibodies occur in 7% of human AIHA cases; this is
referred to as mixed AIHA. Sokol and co-workers report
only one case of secondary mixed AIHA due to Myco-
plasma infection, i.e. M. pneumoniae [8].
Mixed AIHA has been found in M. suis-induced IAP.
Cold IgM agglutinins targeting glycoproteins on the red
blood cells were observed [9,10]. These cold agglutinins
occur about four weeks after experimental infection
with M. suis. During the acute stage of IAP (clinical
attack), acute anaemia, hypoglycaemia and icteroanae-
mia accompanied by high mortality occur. It is assumed
that the severe anaemia observed in pigs suffering from
acute clinical signs is due to a combination of direct
damage to the red blood cells by M. suis attachment
and invasion, and upregulation of cold and warm auto-
reactive antibodies directed against red blood cell com-
ponents. In previous studies, these autoreactive warm
IgG antibodies have been shown to overwhelm the spe-
cific immune response to M. suis [11].
In this study, sera from experimentally M. suis-
infected pigs were screened for the presence of warm
IgG antibodies by testing their reactivity with blood pre-
parations from healthy pigs. The detection and charac-
terisation of the host proteins acting as autoantigens
was a main issue. Earlier studies, i.e. serological pro-
teome analysis [12], yielded some evidence that actin is
a target protein for the autoreactive antibodies detected
during the acute state of the disease. This was observed
in both one- and two-dimensional immunoblots.
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screened for reactivity with porcine muscular (a-) and
cytoskeletal (b-) actin.
Results
Study design and screening of porcine sera for
autoreactive antibodies
A collection of sera obtained from experimentally
M. suis-infected pigs was available from earlier studies
[11,13]. The sera were divided into two groups according
to their history. Group 1 (36 sera) were derived from pigs
(n = 13) that had been vaccinated with MSG1 prior to
splenectomy and challenge with M. suis.I nv i e wo ft h e
known major occurrence of autoreactive IgG antibodies
during clinical attacks [11], the sera used for the present
s t u d yw e r ed r a w na tf o l l o w i n gt i m ep o i n t s :I ,2 1d a y s
post-immunisation and 14 days prior to M. suis infection;
II, during the first clinical attack (on average 10 days
after infection); III, 14 days apart; IV, during the second
clinical attack (on average 6 weeks post-infection). Owing
to animal deaths, fewer sera were analysed at time points
II (n = 11), III (n = 6) and IV (n = 6). Group 2 (40 sera)
originated from 10 pigs that had not been immunised
prior to splenectomy and M. suis infection. For this
study, sera taken prior to infection (I), during the first
clinical attack (II), between the first and the second clini-
cal attacks (III) and during the second clinical attack (IV)
were considered. In total, 76 sera (36 of group 1 and 40
of group 2) were screened by ELISA for reactivity with
IgG-depleted antigen preparations from healthy pigs (neg
Ag). OD values were normalised to the negative control.
The cut-off value was determined to be 0.226 (three
times the standard deviation of negative controls).
Figure 1A gives an overview of the screening results.
At time point I, prior to splenectomy and infection,
8 4 . 6 %o fg r o u p1s e r a( i m m u n i s e dw i t hM S G 1 )a n dn o
group 2 sera showed autoreactivity. There was a shift in
antibody response during the first clinical attack. The
reactivity of group 1 sera decreased to 45.5%, and 60.0%
of group 2 sera reacted with neg Ag. Between two clini-
cal attacks, 83.3% of the sera from immunised pigs
showed autoreactivity, and antibodies to neg Ag were
completely down-regulated in the group 2 sera. During
the second clinical attack, 100.0% of sera in group 1 and
80.0% of those in group 2 were autoreactive. Reactivities
differed significantly between the groups at every time
point. The P values were ≤ 0.006, 0.010, 0.004 and 0.043
for I, II, III and IV, respectively. In only one of the 23
animals were there no autoreactive antibodies in sera
taken at any time point. Figure 1B shows the occurrence
of autoreactive antibodies over the time course of infec-
tion in each group. The vaccinated animals representing
group 1 had already produced autoreactive antibodies
after immunisation with MSG1 and prior to infection
and splenectomy, and these antibodies remained at a
similar level for time points II, III and IV. The animals
of group 2 showed no autoreactive antibodies before
infection, up-regulated antibodies to neg Ag at time
point II (1
st clinical attack), down-regulated antibodies
below the cut-off value between clinical attacks, and
production of autoreactive antibodies again during the
2
nd clinical attack (IV).
Reactivity with porcine a-actin
In order to identify the autoantigens, the autoreactive
sera (n = 36) were further tested with IgG-depleted ery-
throcyte lysates (ECL) and with porcine a-actin. Earlier
studies suggested actin as a potential target of warm
autoreactive antibodies (one- and two dimensional
immunoblots) [12]. In 32 sera (88.9%), antibodies reac-
tive with both preparations were detected. Linear regres-
sion for neg Ag with ECL and a-actin revealed R
2 values
of 0.732 and 0.744, respectively (Fig. 2).
The actin reactivity was shown to be species-specific,
i.e. a significantly lower reactivity was observed with
rabbit a-actin than with porcine a-actin. The mean OD
values at l = 405 nm were 0.408 ± 0.136 and 0.793 ±
0.185 for rabbit and porcine a-actin, respectively.
Reactivity with porcine b-actin
The erythrocyte contains cytoskeletal actin (b-actin).
This actin form is highly homologous but not identical
to muscle actin (a-actin). Since b-actin was not com-
mercially available, the gene was synthetically produced
and adapted to E. coli c o d o nu s a g e .T h ep r o t e i nw a s
expressed, purified and used for the experiments
(Fig. 3). Sera reactive with a-actin were tested further
with b-actin. They were all positive for both actin
forms. Group 1, the MSG1-immunised animals, showed
a strikingly stronger reactivity with b-actin than with
a-actin (P ≤ 0.0002). No significant difference was seen
in the group 2 animal sera (P ≤ 0.2034).
Isotypes of autoreactive antibodies to actin
In warm autoimmune haemolytic anaemia, IgG1 and
IgG3 antibodies predominate [14]. These antibodies are
recognised preferentially by macrophages. To gain
insight into the autoreactive mechanisms occurring dur-
ing an M. suis infection, secondary antibodies to porcine
IgG1 and IgG2 were used to evaluate the subtypes of
actin-reactive antibodies in group 1. No secondary anti-
bodies to porcine IgG3 were available. The IgG1/IgG2
and IgG2/IgG1 ratios were calculated to be 1.280 ±
1.796 and 2.727 ± 1.925, respectively (P ≤ 0.018).
Search for shared epitopes between MSG1 and actin
Reactivity with actin was observed in MSG1-vaccinated
immunocompetent animals prior to splenectomy and
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lar mimicry, we evaluated the reactivity of a rabbit
serum targeting recombinant MSG1 with actin and vice
versa, i.e. the reactivity of a serum recognising porcine
actin with MSG1. Cross-reactivity was observed (Fig. 4).
Therefore, the protein sequences of porcine actin and
MSG1 were used as input to an epitope finder program.
The program allows epitopes potentially presented by
SLA molecules to B-cells to be identified with high
probability. SLA-2*0201 would present the peptide
LTLKYPIEH derived from actin and the peptide
RTLKYYISL derived from MSG1. Both peptides are
nine amino acids in length and share a sequence identity
of 55%. This peptide is identical in both actin forms.
Discussion
In M. suis infections, autoreactive antibodies are of cen-
tral importance for inducing anaemia [9,10]. Recently
we showed that warm autoreactive antibodies of the iso-
type IgG are up-regulated during the acute phase of
experimentally-induced M. suis infection [11]. Two-
dimensional immunoblot analysis revealed that actin is
potentially recognised by these antibodies [11,12]. Actin
is known to play a role in autoimmune hepatitis type 1
(AIH-1), where F-actin-reactive antibodies are character-
istic [15]. To our knowledge, this is the first report and
evidence for autoreactive antibodies directed against
actin in warm AIHA. In particular, characterising these
autoantigenic structures is an essential basis for
Figure 1 Serum reactivities with neg Ag at several time points (I to IV). A: Group 1 comprises animals (n = 13) that were immunised with
MSG1 prior to infection with M. suis and splenectomy. Pigs in group 2 (n = 10) were splenectomised and infected with M. suis. B: Occurrence of
autoreactive antibodies over the time course of infection; mean values for each group are shown. Bars indicate standard errors of the means.
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associated with M. suis infections or in general. Typi-
cally, autoreactive antibody production is induced by a
misguided up-regulation of naturally-occurring B-cells
specific for self-antigens, the occurrence of altered self-
antigens, the appearance of previously cryptic antigens,
and loss of tolerance to self-antigens due to molecular
mimicry.
Antibodies recognising cytoskeletal components such
as actin, spectrin or band 3 are physiological components
of tissue homeostasis and B-cell clones specific for actin
patrol continually [16]. A misregulation due to M. suis
infection could lead to excessive thymus-independent
proliferation of these B-cell clones [10]. Other Myco-
plasma species, e.g. M. pneumoniae, are polyclonal B-cell
activators of mouse splenocytes [17]. Further, Zachary
and Smith have described such misdirected immune
responses in M. suis infections [10]. Interestingly, actin-
targeting IgG antibodies are up-regulated during the first
clinical attack when M. suis is present in large numbers.
This provides evidence for the hypothesis of a direct
mitogenic stimulus derived from M. suis leading to non-
specific B-cell stimulation.
A further explanation for the development of auto-
reactive antibodies is that damage to red blood cells
makes hidden cytoskeletal proteins accessible to
Figure 2 Actin as autoantigen and species specificity. Linear regressions between reactivities with neg Ag and ECL (A) and with neg Ag and
a-actin (B) are shown for 16 sera. In addition, 95% confidence and 95% prediction bands are shown. C: comparison between reactivities with
rabbit and pig a-actin.
Felder et al. BMC Veterinary Research 2010, 6:18
http://www.biomedcentral.com/1746-6148/6/18
Page 4 of 9Figure 3 Purification of porcine b-actin and comparison of serum reactivities with a-actin and b-actin.A :C o o m a s s i e - s t a i n e d
polyacrylamide gel showing purification of recombinant porcine b-actin. Nickel affinity chromatogryphy (1) and electro-elution (2) are shown.
Protein mass standards in kDa are indicated in column S; B: Comparison of reactivity with a-actin and b-actin. Group 1, i.e. immunised animals,
showed significantly stronger reaction with cytoskeletal actin (P ≤ 0.0002). No difference between a- and b-actin reactivities was observed in
group 2 sera (P ≤ 0.2034).
Figure 4 Cross-reactivity of rabbit hyperimmune sera between actin and MSG1. A: Westernblot reactivity of MSG1 with a rabbit serum
specific for porcine a-actin; B: Porcine actin is detected by a rabbit serum specific for MSG1, column S in A and B indicates protein masses in
kDa; C: potential cross-reactive nonapeptides that would be presented by SLA*002 molecule. They share an identity of 55%.
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non-self and elicit an immune response. It has been
hypothesised that autoimmune epitopes on red blood
cells may be result from contact with proteolytic
enzymes [18]. Electron microscopic studies have
revealed a close association between M. suis cells and
erythrocytes and striking membrane deformations on
the host cells [19,20]. Considering loads of up to 4000
M. suis cells per erythrocyte, it is quite evident that the
cytoskeleton is modified by attachment and invasion.
The last explanation for the induction of autoreactive
antibodies directed against host actin in M. suis infec-
tions is molecular mimicry. In this process, a peptide
derived from a pathogen and presented by MHC II
must be capable of activating a self-reactive helper
T cell and, therefore, stimulating specific antibody-
producing B-cells.
Remarkably, in sera obtained from pigs immunised
with MSG1, autoantibodies against actin were already
detectable after immunisation but prior to splenectomy
and challenge with M. suis. These findings strongly
support the hypothesis that MSG1 is involved in indu-
cing autoimmunity by molecular mimicry. Evidence for
cross-reactivity between MSG1 and actin was found by
western blotting using hyperimmune rabbit sera. To
test whether actin and M. suis actually share potentially
cross-reactive epitopes, the NetMHCpan algorithm was
used and gave a positive result [21]. Porcine SLA-
2*0201 (swine lymphocyte antigen) would strongly bind
and therefore present the deduced peptides LTLKY-
PIEH (from porcine actin) and RTLKYYISL (from
MSG1) to the same circulating T-cells. The identity
between these peptides was calculated to be 55%,
which is enough for cross-reactivity. Degeneracy in
both the TCR and MHC peptide-binding motifs
reduces the sequence-specific requirement to only a
few crucial residues [22-24]. It remains to be elucidated
by systematic in vitro stimulation assays whether these
peptides actually play a role in the pathogenesis of
AIHA due to M. suis infection.
In RBCs and many other cell types b-actin is part of
the cytoskeleton; a-actin predominates only in muscle
cells. If the strongly b-actin-binding antibodies identified
encounter their target ubiquitously, RBCs would not be
the only cells affected. There is evidence that lympho-
cytes and epithelial cells are harmed during M. suis
infection (unpublished observations). Cytoskeletal pro-
teins in cells with intact plasma membranes are cryptic
for antibodies. However, if the cell is injured by interac-
tion with M. suis, b-actin would become accessible.
Antibodies recognising this actin opsonise the red blood
cells which leads to their removal from the circulatory
system and therefore to anaemia. Notably, clinical signs
expected by autoreactive processes targeting muscle
actin (a-actin) were observed.
In autoimmune diseases including AIHA, misdirected
IgG1 and IgG3 antibodies play an important role because
they bind efficiently to FcReceptorIII (FcRIII) molecules
on macrophages [14,25]. Interestingly, the antibodies
that predominantly recognised actin were of the subtype
IgG2rather than IgG1. However, a definitive subtype
assignment was not feasible owing to high standard
deviations. Immune complexes with the IgG2 subtype
activate the alternative complement cascade pathway
and are important in defence against encapsulated bac-
teria [26,27]. However, the consequences of autoreactive
IgG2 up-regulation during M. suis infection remain
unclear. Unfortunately, no statement about the presence
of IgG3 antibodies and their role in M. suis infection
can be given since secondary antibodies for this porcine
subtype were not available.
Conclusions
Overall, we record that autoreactive IgG antibodies up-
regulated during infectious porcine anaemia induced by
M. suis recognise actin. These autoreactive antibodies
are obviously involved in the pathogenesis of the severe
anaemia observed during the infection. An interplay of
several mechanisms is assumed, i.e. a blastogenic
response due to unspecific lymphocyte proliferation,
direct damage to red blood cells and molecular mimicry.
To our knowledge, this is the first report of autoreactive
actin antibodies in relation to AIHA. In our opinion, the
experimentally M. suis-infected splenectomised pig
represents a useful model for investigating AIHA
because of the controllable inducible symptoms.
Methods
Preparation of screening antigens
To screen for autoreactive antibodies, blood from
healthy pigs was prepared as previously described for M.
suis antigen preparations [28,29] with slight modifica-
tions. Briefly, blood cells from M. suis-negative pigs
were sedimented by centrifugation at 300 × g for 15
min at room temperature (RT). Plasma and buffy coat
were discarded. The erythrocytes were suspended in
phosphate-buffered saline (1 × PBS; Biochrom Ag, Ber-
lin, Germany) containing 0.15% Tween20 and 3% EDTA
and incubated for 20 min at RT with shaking. Debris
and erythrocytes were removed by low-speed centrifuga-
tion (500 × g, 20 min, RT). The supernatant was centri-
fuged at 25,000 × g for 120 min at 4°C. The resulting
pellet was resuspended (1 mg/ml) in sterile 1 × PBS.
The preparation was depleted of IgG and albumin using
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biochem, Merck, Geneva, Switzerland) according to the
manufacturer’s recommendations and stored in 100 μl
aliquots at -80°C until further use. The preparations
were referred to as negative antigen (neg Ag).
Sera reactive with neg Ag were further tested with
IgG-depleted erythrocyte lysate (ECL) and with several
actin preparations. ECL was prepared by hypotonic lysis
of erythrocytes from a healthy pig. Red blood cells were
washed three times with 1 × PBS (500 × g, 15 min, RT)
and resuspended in ice cold lysis buffer (5 mM Na2PO4,
1 mM EDTA, pH 7.6, Sigma) at a 1:1 (v/v) ratio. After
incubation on ice for 5 min, the ghosts (remnants of
lysed cells) were pelleted (30,000 × g, 15 min, 4°C). This
procedure was repeated until the pellet turned white.
The white pellet was washed in 1 × PBS, homogenised
by ultrasonication on ice and IgG depleted. The concen-
tration was set to 1 mg/ml with 1 × PBS and the sus-
pension was stored in 1 ml aliquots at -80°C until
further use.
Pig and rabbit muscle actin (a-actin) were obtained
from Sigma, Buchs, Switzerland. Porcine cytoskeletal
actin (b-actin) was not commercially available and was
therefore produced recombinantly (see below).
Screening of sera by ELISA
Sera were obtained in previous studies using a splenec-
tomized pig model for experimental M. suis infections
[13]. They were divided into two groups. Group 1 con-
sisted of sera from animals that had been immunised
with a recombinant immunogenic surface protein of
M. suis (MSG1) [13] prior to splenectomy and M. suis
infection. Group 2 sera were from splenectomised,
M. suis-infected pigs that had not been immunised [11].
The studies were approved by the government of upper
Bavaria under the registration number 211-2531-77/98
and were performed in compliance with animal care
legal prescriptions.
The porcine sera were screened for autoreactivity by
ELISA as described previously [30]. Briefly, 100 ng of
IgG-depleted neg Ag were coated on individual wells of
microtiter plates. Sera were diluted 1:100 in 1 × PBS
containing 0.05% (v/v) Tween20 (PBST) and tested in
duplicate. Sera were drawn prior to M. suis infection,
after immunisation in group 1 (I), during the first clini-
cal attack (II), between first and second clinical attacks
(III), and during the second clinical attack (IV). Sera
reactive with neg Ag were further tested for reactivity
with ECL, pig and rabbit a-actin, and porcine b-actin.
The protein concentration was 100 ng/well. OD values
(l = 405 nm) were determined and normalised to a
negative control (pool of 10 sera from healthy pigs).
Cut-off values were set at three times the standard
deviation of the negative controls.
To determine the subtypes of autoreactive antibodies,
monoclonal antibodies targeting porcine IgG1 and IgG2
(Prionics, Schlieren, Switzerland) were diluted 1:1000 in
PBST. Horse-radish-peroxidase-labelled antibodies
against mouse IgG (Sigma) diluted 1:5000 in PBST were
used for detection.
Cloning and expression of porcine cytoskeletal actin
Porcine cytoskeletal actin (b-actin) was not commercially
available. Using the encoding mRNA sequence (Genbank:
AY550069), the gene was de novo synthesised and opti-
mised for E. coli codon usage by Eurofins (Martinsried,
Germany). For cloning, specific recognition sites for
endonucleases were introduced (XhoIa tt h e5 ’ end and
HindIII at the 3’ end). For expression, the gene was
ligated into the expression vector pBadMycHisA (Invitro-
gen) using T4 ligase from Roche, Basel, Switzerland
(overnight, 14°C). The insert-containing vector was trans-
formed into E. coli LMG194 (Invitrogen). The E. coli
transformants were grown at 37°C, and expression of the
recombinant porcine b-actin was induced by adding
0.02% arabinose at OD600 =0 . 4 .T h ec e l l sw e r ei n c u b a t e d
f o raf u r t h e r4ha t3 7 ° Ca n dt h e6 × H i s - t a g g e dp r o t e i n
was purified by nickel affinity chromatography (GE
Healthcare, Glattbrugg, Switzerland) according to the
manufacturer’s recommendations. To extract the protein
from inclusion bodies, 8 M urea was used for purifica-
tion. The recombinant protein was further purified by
electro-elution from 10% polyacrylamide gels using an
Electro-Eluter Model 422 (Biorad, Reinach, Switzerland).
The eluted protein was precipitated by adding three
volumes of ice cold acetone and incubating overnight at
-20°C. The protein was harvested by centrifugation
(10,000 × g, 90 min, 4°C), allowed to dry, resuspended in
1 × PBS, and stored in aliquots of 1 mg/ml at -80°C.
Production of hyperimmune sera
One milligram of protein (recombinant MSG1 [13],
recombinant porcine b-actin or porcine a-actin (Sigma,
Buchs, Switzerland)) was mixed with complete Freund’s
adjuvant (Sigma) at a 1:1 (v/v) ratio and injected subcu-
taneously into rabbits. Two booster injections (the pro-
teins were mixed 1:1 (v/v) with incomplete Freund’s
adjuvant) were given two and four weeks later. Six
weeks after the first injection the rabbits were bled; the
serum was harvested and stored in aliquots at -20°C.
Immunisations were approved by the Veterinary Office
of Zurich and conducted under the registration number
144/2008 in accordance with legal prescriptions.
Western blotting
The cross-reactivity of rabbit sera against MSG1 and
porcine a-actin between a-actin and MSG1 was tested
by western blotting as described previously [11]. Briefly,
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gels containing 1% SDS (w/v) and transferred to a nitro-
cellulose membrane (Whatman Protran®, GE Health-
care). Free binding positions on the membrane were
blocked with skim milk (Sigma, 2% w/v in Tris buffered
saline, TBS) and probed with rabbit hyperimmune sera
(diluted 1:100 in TBS containing 2% skim milk powder)
against recombinant MSG1 and a-actin, respectively. A
secondary antibody reactive with pig IgG (Sigma) and
coupled to horseradish peroxidase (HRP) was used,
diluted 1:5000 in TBS containing 2% (w/v) skim milk
powder. The substrate for the HRP was H2O2 (Sigma);
4-Chloro-1-naphthol (Sigma) was used as chromogen.
The reaction was stopped by adding MQ water (Milli-
pore, Zug, Switzerland).
Search for cross-reactive epitopes
To identify potential cross-reactive epitopes, an epitope
finder program referred to as the NetMHCpan algo-
rithm was used [21]. Published protein sequences of
MSG1 (UniProtKB/TrEMBL:Q05G10), porcine a-actin
(Swiss-Prot:P68137.1) and porcine b-actin (Swiss-Prot:
Q6QAQ1.2) were used as input.
Statistical analysis
The ELISA OD values measured at 405 nm were com-
pared by linear regression models using SigmaPlot soft-
ware, Version 10.0 (SPSS Inc., Chicago, IL, U.S.A). To
show independence of values between the two groups,
the unpaired Student’s t-test was applied (significant dif-
ference if P ≤ 0.05).
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